Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM therapy in hypertensive pacemaker patients in collaboration with Medtronic, plc in December 2023 Orchestra BioMed and Terumo...